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A 49-year-old white man was admitted to the emergency department with nausea and diarrhea of 11
hours duration. He had experienced crampy abdominal pain as well. He reported that his stools had
been dark and malodorous. He had no prior history of gastrointestinal disorders, nor travel, unusual
oral or liquid intake. There was a remote history of alcohol abuse, but no hepatitis or cirrhosis. Recent
alcohol intake was denied by the patient. He had no medical allergies. His past medical history was
pertinent for a history of hypertension, congestive heart failure, and a dual chamber pacemaker
insertion. There was no history of diabetes mellitus, smoking, or myocardial infarction. Medications
included lisinopril, a small dose of aspirin daily, and thyroid supplement. Family history was negative for
cardiomyopathy, sudden cardiac death, gastric or duodenal ulcers, colon cancer, or any congenital
abnormalities. [West J Emerg Med. 2011;12(4):565–566.]
Exam revealed a mildly obese pale gentleman in overt
distress. His vitals in triage were a temperature of 97.68F, blood
pressure of 116/49, pulse of 58, and respiration rate of 24.
He was pale and diaphoretic. Exam of the head and neck
revealed that he was anicteric, had no parotid enlargement, no
telangiectasias, nor petechiae, no oral blood or lesions. His
neck was unremarkable with nondistended neck veins, and no
thyromegaly or tracheal shift. His chest was clear with a
pacemaker pouch seen in the left deltopectoral area. Cardiac
exam revealed cool moist slow capillary reﬁll, a heart rate of
120 per minute, and normal heart sounds without rub or S3.
Abdomen exam showed no liver enlargement, hypoactive
bowel sounds, no bruit or mass, no discrete tender areas.
Genitourinary evaluation was unremarkable for testicular
atrophy. He had 4-plus heme-positive stool with melena on
exam of the rectum. Extremities were devoid of edema,
clubbing, rashes, or petechiae. Neuro exam was nonfocal; he
was initially a poor historian with generalized weakness. An
arterial blood gas (ABG) with electrolytes and hemoglobin was
ordered to get an immediate result and triage the acuity of the
gastrointestinal bleeding.
The patient had electrolytes of sodium 128, potassium 5.7
(hemolyzed specimen), low calcium of 4.3, and a hemoglobin of
10.7. The ABG suggested a metabolic debt with a hydrogen
carbonate of 17.1. Glucose was elevated at 224 mg/dL. He was
also immediately placed on the monitor, both for the complaint,
the potential of atypical presentation for myocardial ischemia,
and because he had a pulse discrepancy between triage and the
initial clinical exam. On the monitor, he was seen to have a pulse
of nearly 116 to 120 beats per minute, which was sinus
tachycardia, alternating with a sinus rhythm at 60 beats per
minute, and with apparent 2:1 block. His initial
electrocardiogram (ECG) was recorded and is shown in the
Figure. It shows sinus rhythm (sinus tachycardia) at
approximately 120 to 128 beats per minute and 2:1 block for the
ﬁrst 6 ventricular beats, followed by 1:1 pacing at approximately
118 beats per minute. (The P-to-P wave interval measures just
slightly longer in the last half of the ECGs). The patient received
aggressive normal saline ﬂuid resuscitation intravenously,
followed by intravenous omeprazole and odansetron. As his
hypovolemia corrected, he was noted to have a slowing of his
sinus rate and resumption of consistent 1:1 pacing on the
monitor. There was no evidence of myocardial injury on the labs
for troponin. The patient went to the intensive care unit for
evaluation and gastrointestinal and surgical consults.
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Postventricular atrial refractory period (PVARP) plus
atrioventricular (AV) interval equals or limits the upper rate
limit. The patient has a physiologic sinus tachycardia, but the
pacemaker is not programmed for rates this high. This ECG
shows what appears to be 2:1 block in a 2-chambered
pacemaker that is in AV synchronous mode, ie, the pacemaker
paces the ventricle (synchronizes to the atrial impulse) at a
programmed AVinterval if no (intrinsic) ventricular beat is seen.
This mode is used in patients with stable sinus function but with
a disorder of AV conduction, such as prior complete heart block.
Dual pacemakers are also programmed to have an upper
rate limit to avoid extremely fast heart rates if the patient
develops sinus tachycardia or atrial ﬂutter or ﬁbrillation or if
they have retrograde conduction through the AV node. The
pacemaker will track or pace heart rates at the prespeciﬁed AV
interval up to the upper rate limit. Upper rate limits are
commonly 120 to 140 beats per minute. Upper rates above this
are seldom useful in patients with already compromised cardiac
function; thus, the pacemaker programming prevents unwanted
congestive symptoms or prolonged tachycardia. PVARP is the
period during which the pacemaker is programmed not to
recognize or respond to a signal from the atrium. Pacemakers
will not synchronize to or pace sinus or atrial impulse during
this interval. The sum of the AV interval plus the PVARP
deﬁnes the upper rate limit. Initially, in pacemaker history, this
prevented dual-chambered pacemakers from developing
endless loop tachycardia or pacemaker mediated tachycardia
(PMT) from retrograde P waves (up to 50% of the population
conducts retrograde through the AV node; this is called VA
conduction). Thus, dual chambered pacemakers have rate limits
that are both physiological and protective for the patient.
1–3
It should also be mentioned that many newer
pacemakers have algorithms that protect against PMT by
automatically extending the PVARP when the upper rate
limit is reached. Additionally, the newest generation of dual
mode, dual chamber, and dual sensing pacemakers can often
distinguish retrograde vs antegrade conduction of P waves,
allowing for physiologic tachycardias to be sustained and
nonphysiologic (retrograde P waves) terminated.
4,5 This
patient, usually hypertensive, was in incipient hypovolemic
shock. The heart rate of 58 was likely a factor in his initial
limited responses and poor perfusion. However, volume
resuscitation rather than any change in his pacemaker
programming was the only remedy needed. An expensive,
time-consuming evaluation by a pacemaker interrogation or,
worse, external pacing was unnecessary, since this
phenomenon of PVARP was known to exist in dual-
chambered pacemakers.
With subtle slowing of the sinus rate, the patient had
perfect 1:1 tracking. This phenomenon of alternating (as shown
in our Figure) can only happen when the sinus rate is very near
the upper rate limit. Even a few millisecond differences in the
sinus impulse rate can change the tracking from 1:1 to 2:1. The
ECG captured this phenomenon occurring. As long as the
patient had a heart rate under 118 beats per minute, he tracked
perfectly, indicating his PVARP was thecause of thepseudo 2:1
conduction or block.
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Figure. Twelve-lead electrocardiogram shows sinus tachycardia
with evident 2:1 block of paced beats followed by 1:1 atrioventricular
synchronous pacing at 118 beats per minute.
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